Jack Phillips - 04 Apr 2022 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Reporting relationship: Chief Executive Officer
Issuer ticker: AXDX
Reported as of: 04 Apr 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Apr 2022, 17:06:54 UTC
Prior SEC filing: 30 Mar 2022
Next SEC filing: 28 Apr 2022
Source filing: View source filing
Reporting owner signature: /s/ Steven Reichling, attorney-in-fact

Key filing fact

Jack Phillips filed Form 4 for Accelerate Diagnostics, Inc (AXDX) on 06 Apr 2022.

Key facts

This page summarizes Jack Phillips's Form 4 filing for Accelerate Diagnostics, Inc (AXDX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 06 Apr 2022, 17:06.

Change

Previous filing in this sequence was filed on 30 Mar 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AXDX transaction Derivative

Employee Restricted Stock Units

Award

Transaction value: $0
Shares: +888,060
Change %
Price: $0.000000
Shares after: 888,060
Date: 04 Apr 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 888,060
Exercise price
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Footnote F2

The reporting person received restricted stock units on April 4, 2022, of which 40% vests on April 4, 2024 and the remaining 60% will vest on April 4, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Footnote F3

Not Applicable.